Pay in 4 interest-free payments of $42.38 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Laduviglusib induces autophagy
Galunisertib (LY2157299) is an oral and selective TGF-β receptor type I (TGF-βRI) kinase inhibitor with an IC50 of 56 nM
is a dual SphK and protein kinase C (PKC) activator
Gangliosides are acidic glycosphingolipids that form lipid rafts in the outer leaflet of the cell plasma membrane
Thus vaspin may represent a novel biomarker for obesity and impaired insulin sensitivity and might serve as a new therapeutic target of metabolic syndrome
TT-100-DH Block B, 54 x 0.5ml Pack Size:1 unit Laduviglusib induces autophagyBlock B for Dry Bath Incubator TT 100 DH, 54 x 0. 5ml
US$ 999.50
US$ 1099.50
US$ 1149.50
US$ 1099.50
US$ 1099.50
US$ 1199.50
US$ 1099.50
US$ 999.50
US$ 999.50